Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  • Tracking the eyes: The keys to consumers' plant preferences

  • Naming people, objects in baby's first year may offer learning benefits years later

  • Meth users face substantially higher risk for getting Parkinson's disease

  • First real-time mri-guided brain surgery for Parkinson's in southern California

  • How, where the brain converts external inputs into behavioral responses

  • Teen contraband smokers more likely to use illicit drugs: Study

  •